These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26621504)

  • 1. CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2/STAT3 and p38/MAPK signaling pathway.
    Li CH; Xu LL; Zhao JX; Sun L; Yao ZQ; Deng XL; Liu R; Yang L; Xing R; Liu XY
    Inflamm Res; 2016 Mar; 65(3):193-202. PubMed ID: 26621504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of CXCL16/CXCR6 in fibroblast-like synoviocytes in rheumatoid arthritis and its role in synoviocyte proliferation].
    Zhang X; Zhao JX; Sun L; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):663-668. PubMed ID: 28816285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of 4-hydroperoxy cyclophosphamide and methotrexate inhibits IL-6/sIL-6R-induced RANKL expression in fibroblast-like synoviocytes via suppression of the JAK2/STAT3 and p38MAPK signaling pathway.
    Niu HQ; Zhao WP; Zhao XC; Luo J; Qin KL; Chen KL; Li XF
    Int Immunopharmacol; 2018 Aug; 61():45-53. PubMed ID: 29803913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes.
    Choe JY; Park KY; Park SH; Lee SI; Kim SK
    Arthritis Res Ther; 2013 Feb; 15(1):R26. PubMed ID: 23406906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways.
    Li X; Kim KW; Cho ML; Ju JH; Kang CM; Oh HJ; Min JK; Lee SH; Park SH; Kim HY
    Immunol Lett; 2010 Jan; 127(2):100-7. PubMed ID: 19900478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-29 induces receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes via MAPK signaling pathways.
    Xu L; Feng X; Shi Y; Wang X; Kong X; Zhang M; Liu M; Tan W; Wang F
    Int J Rheum Dis; 2015 Nov; 18(8):842-9. PubMed ID: 26420479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.
    Hashizume M; Hayakawa N; Mihara M
    Rheumatology (Oxford); 2008 Nov; 47(11):1635-40. PubMed ID: 18786965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulating peroxisome proliferator-activated receptor-gamma coactivator-1 beta alleviates the proinflammatory effect of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting extracellular signal-regulated kinase, p38 and nuclear factor-kappaB activation.
    Zhou JJ; Ma JD; Mo YQ; Zheng DH; Chen LF; Wei XN; Dai L
    Arthritis Res Ther; 2014 Oct; 16(5):472. PubMed ID: 25367151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect and mechanism of 1,25-dihydroxy vitamin D3 on RANKL expression in fibroblast-like synoviocytes and osteoclast-like cell formation induced by IL-22 in rheumatoid arthritis.
    Wen H; Liu Y; Li J; Wei D; Liu D; Zhao F
    Clin Exp Rheumatol; 2018; 36(5):798-805. PubMed ID: 29465363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANKL downregulates cell surface CXCR6 expression through JAK2/STAT3 signaling pathway during osteoclastogenesis.
    Li C; Zhao J; Sun L; Yao Z; Liu R; Huang J; Liu X
    Biochem Biophys Res Commun; 2012 Dec; 429(3-4):156-62. PubMed ID: 23142594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts.
    Kim KW; Kim HR; Park JY; Park JS; Oh HJ; Woo YJ; Park MK; Cho ML; Lee SH
    Arthritis Rheum; 2012 Apr; 64(4):1015-23. PubMed ID: 22034096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway.
    Ruth JH; Haas CS; Park CC; Amin MA; Martinez RJ; Haines GK; Shahrara S; Campbell PL; Koch AE
    Arthritis Rheum; 2006 Mar; 54(3):765-78. PubMed ID: 16508941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Kim KW; Cho ML; Oh HJ; Kim HR; Kang CM; Heo YM; Lee SH; Kim HY
    Immunol Lett; 2009 May; 124(1):9-17. PubMed ID: 19446344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway.
    Min HK; Won JY; Kim BM; Lee KA; Lee SJ; Lee SH; Kim HR; Kim KW
    Arthritis Res Ther; 2020 Sep; 22(1):222. PubMed ID: 32972460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis.
    Nanki T; Shimaoka T; Hayashida K; Taniguchi K; Yonehara S; Miyasaka N
    Arthritis Rheum; 2005 Oct; 52(10):3004-14. PubMed ID: 16200580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
    Tsushima H; Okazaki K; Ishihara K; Ushijima T; Iwamoto Y
    Arthritis Res Ther; 2015 Feb; 17(1):31. PubMed ID: 25811130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-17 increases the expression of Toll-like receptor 3 via the STAT3 pathway in rheumatoid arthritis fibroblast-like synoviocytes.
    Lee SY; Yoon BY; Kim JI; Heo YM; Woo YJ; Park SH; Kim HY; Kim SI; Cho ML
    Immunology; 2014 Mar; 141(3):353-61. PubMed ID: 24708416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin stimulates interleukin-6 production via janus kinase 2/signal transducer and activator of transcription 3 in rheumatoid synovial fibroblasts.
    Muraoka S; Kusunoki N; Takahashi H; Tsuchiya K; Kawai S
    Clin Exp Rheumatol; 2013; 31(4):589-95. PubMed ID: 23622344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
    Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N
    Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Kim HR; Kim KW; Jung HG; Yoon KS; Oh HJ; Cho ML; Lee SH
    Arthritis Res Ther; 2011 Mar; 13(2):R43. PubMed ID: 21401926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.